Minimally invasive method outperformed tape stripping in a recent study.
The most critical step is understanding what value precision medicine brings to your practice, and where it can have greatest impact from both a clinical and business perspective.
A recent study dove into how precision medicine can be used to better target inflammatory skin disease and provide physicians with better treatment regimens.
Darrell S. Rigel, MD, MS, FAAD, answers the question of what is up coming in the world of dermatology in the way of precision medicine.
Mindera Health and a national health insurance company launched a pilot program to improve moderate-to-severe psoriasis management with precision medicine.
Recent data tracks the first realization of precision medicine for patients with psoriasis.
Click here to answer this weeks poll.
In 2023 as many as 11 biosimilars to Humira are headed for the US market.
A phase 3 study conducted by Amgen found that the company’s ustekinumab biosimilar was as safe and efficacious as the reference product (Stelara) in patients with moderate to severe plaque psoriasis.
Experts explored out-of-the-box solutions for treating challenging skin and hair disorders at the American Academy of Dermatology (AAD)’s 2022 Annual Meeting held March 25 to 29, 2022, in Boston, Massachusetts.